☆ 4.7 Article

Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis

Adrian Richter et al.

Summary: Two BTZ043-derived benzisothiazolinones (BITs) with antimycobacterial activity were reported, confirming their molecular structures. In contrast, O-acyl benzisothiazol-3-ols, which are constitutionally isomeric, showed little or no antimycobacterial activity in vitro.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Vaccine-Induced Subcutaneous Granulomas in Goats Reflect Differences in Host-Mycobacterium Interactions between BCG- and Recombinant BCG-Derivative Vaccines

Elisabeth M. Liebler-Tenorio et al.

Summary: This study compares the development of tuberculous granulomas at the site of BCG vaccination and its recombinant derivatives in goats. The results show that granulomas with central caseous necrosis are induced by both BCG and its recombinant derivatives, although the size and extent of necrosis differ between vaccine strains. The recombinant derivatives induce fewer CD4(+) T and B cells and more CD8(+) cells in the granulomas compared to the parental BCG strain. Furthermore, the numbers of multinucleated giant cells (MNGCs) and cells with lipid bodies are significantly lower in groups administered with the recombinant BCG strains. These findings suggest that the granulomas induced by BCG and its recombinant derivatives in goats can serve as suitable models to compare reactions to different mycobacteria or tuberculosis vaccines.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones

Balungile Madikizela et al.

Summary: The study reports on the limited effectiveness of halogenated nitro-free BTZs against tuberculosis, suggesting that further investigation in this direction may not be a promising approach.

MEDICINAL CHEMISTRY RESEARCH (2021)

添加到收藏夹

Article Infectious Diseases

The pipeline of new molecules and regimens against drug-resistant tuberculosis

Todd A. Black et al.

Summary: The clinical development and regulatory approval of new drugs have significantly advanced the management of drug-resistant tuberculosis, providing all-oral regimens with improved safety and efficacy. Ongoing studies may further optimize treatment regimens, and investigational drugs targeting validated mechanisms offer promise for improved potency and safety compared to first-in-class drugs. New compounds with novel targets are also showing potential to enhance antibacterial activity in anti-TB drug regimens.

JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2021)

添加到收藏夹

Review Medical Laboratory Technology

New tuberculosis drug targets, their inhibitors, and potential therapeutic impact

Gauri S. Shetye et al.

TRANSLATIONAL RESEARCH (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs

Catherine Vilcheze

APPLIED SCIENCES-BASEL (2020)

添加到收藏夹

Review Immunology

Perspective for Precision Medicine for Tuberculosis

Christoph Lange et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents

Lingfeng Liu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Review Chemistry, Medicinal

New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016)

Patricia Bento da Silva et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2017)

添加到收藏夹

Review Chemistry, Medicinal

Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches

Rashmi Tandon et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis

Chao Gao et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

Improving the Tuberculosis Drug Development Pipeline

Dimitrios Evangelopoulos et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2015)

添加到收藏夹

Article Medicine, General & Internal

Drug-resistance mechanisms and tuberculosis drugs

Claudio U Köser et al.

LANCET (2015)

添加到收藏夹

Article Infectious Diseases

In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis

Norma Alejandra Gonzalez-Martinez et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Animal Models of Tuberculosis: Guinea Pigs

Simon Clark et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Vadim Makarov et al.

EMBO MOLECULAR MEDICINE (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Isoniazid Induces Apoptosis Of Activated CD4+ T Cells IMPLICATIONS FOR POST-THERAPY TUBERCULOSIS REACTIVATION AND REINFECTION

Sultan Tousif et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

添加到收藏夹

Review Public, Environmental & Occupational Health

Extensively drug-resistant tuberculosis: epidemiology and management

Alberto Matteelli et al.

CLINICAL EPIDEMIOLOGY (2014)

添加到收藏夹

Review Pathology

Tuberculosis Pathogenesis and Immunity

Jennifer A. Philips et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)

添加到收藏夹

Article Microbiology

In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis

Benoit Lechartier et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

添加到收藏夹

Article Chemistry, Multidisciplinary

Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase DprE1

Claudia Trefzer et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

添加到收藏夹

Article Cell Biology

Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis

Joao Neres et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

添加到收藏夹

Article Chemistry, Analytical

High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions

Brendan Prideaux et al.

ANALYTICAL CHEMISTRY (2011)

添加到收藏夹

Article Microbiology

Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones

Maria Rosalia Pasca et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

添加到收藏夹

Article Immunology

Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug-Tolerant, Not Drug-Resistant, Mycobacterium tuberculosis in the Guinea Pig

Zahoor Ahmad et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis

Vadim Makarov et al.

SCIENCE (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung

Ruchi Jain et al.

PLOS ONE (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

Preclinical testing of new drugs for tuberculosis: current challenges

Anne J. Lenaerts et al.

TRENDS IN MICROBIOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.